Skip to content

Author

Nina Kozlova

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Abstract A142: Circulating tumor DNA as a prognostic biomarker in PDAC: Insights from Real-World Data

Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis with few validated biomarkers for disease monitoring. Circulating tumor DNA (ctDNA) is a promising liquid biopsy-based biomarker, but its clinical utility remains incompletely defined. While most available data focus on early-stage disease, we eva...

Daiane Hemerich Brennan, Nina Kozlova, Gonzalo Lopez et al. · 0 citations
Open access Sep 2026

A noncanonical function of the tyrosine degradation enzyme FAH drives CDK4/6 inhibitor resistance in breast cancer

Resistance to standard-of-care therapies remains a major clinical challenge in the treatment of the most common breast cancer, the hormone receptor–positive (HR+) subtype. Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors improve outcomes in early-stage HR+ disease, yet many patients relapse. Resistance mechanisms of rel...

Jenny M. Hogstrom, Hanna M. Doh, A. Kump et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.